← Eichor
Study identifier: NCT07054723 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Surviving Daily Life

Condition: Stress · Cognitive Change · Breast Cancer  ·  Sponsor: Thomas Jefferson University

PhaseN/A
Planned participants30
Who can joinFemale, 40 Years to no upper limit
Healthy volunteersNo

About this study

The primary goal of this project is to evaluate the feasibility of a 14-day mobile daily diary study among racially diverse breast cancer survivors. Further, the investigators will examine the validity and reliability of the daily stress and daily cognitive performance measures among breast cancer survivors. This pilot project will recruit 30 racially diverse breast cancer survivors (Asian, Black, Latina, and white; ages 40 and older; at least five years post-diagnosis) who are patients at the Sidney Kimmel Comprehensive Cancer Center. The daily diary survey questions will be available in English, Spanish, and Chinese to accommodate the preferred language of the target participants.

This description comes directly from the study's public registry record.

Talk to the study team

Julia Witkowski  ·  215-982-0009  ·  Julia.Witkowski@jefferson.edu

Ana Maria Lopez, MD  ·  215-503-6413  ·  AnaMaria.Lopez@jefferson.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Thomas Jefferson UniversityPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07054723